Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.210 Q1 | 103 | 83 | 241 | 9247 | 912 | 213 | 3.28 | 111.41 | 40.82 | |
2 | Current Medicinal Chemistry | journal | 1.015 Q2 | 202 | 284 | 873 | 35541 | 2862 | 815 | 3.32 | 125.14 | 42.59 | |
3 | Current Molecular Pharmacology | journal | 0.996 Q2 | 49 | 27 | 90 | 2153 | 168 | 75 | 1.90 | 79.74 | 28.00 | |
4 | Current Cancer Drug Targets | journal | 0.951 Q2 | 103 | 69 | 223 | 6431 | 569 | 204 | 2.18 | 93.20 | 44.49 | |
5 | Current Drug Targets | journal | 0.906 Q2 | 119 | 140 | 536 | 14215 | 1303 | 481 | 2.13 | 101.54 | 41.85 | |
6 | Current Pharmaceutical Design | journal | 0.883 Q2 | 183 | 620 | 1828 | 74679 | 5143 | 1667 | 2.66 | 120.45 | 41.54 | |
7 | CNS and Neurological Disorders - Drug Targets | journal | 0.863 Q2 | 96 | 125 | 504 | 9747 | 1140 | 436 | 1.83 | 77.98 | 45.17 | |
8 | Current Vascular Pharmacology | journal | 0.715 Q2 | 69 | 68 | 292 | 5333 | 555 | 233 | 1.71 | 78.43 | 41.22 | |
9 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.674 Q2 | 108 | 174 | 488 | 9129 | 1081 | 454 | 2.02 | 52.47 | 43.09 | |
10 | Mini-Reviews in Medicinal Chemistry | journal | 0.567 Q3 | 107 | 115 | 399 | 12053 | 863 | 366 | 2.08 | 104.81 | 48.82 | |
11 | Reviews on Recent Clinical Trials | journal | 0.498 Q3 | 35 | 43 | 132 | 1860 | 196 | 117 | 0.95 | 43.26 | 41.82 | |
12 | Current Radiopharmaceuticals | journal | 0.389 Q3 | 32 | 27 | 74 | 762 | 86 | 67 | 1.26 | 28.22 | 38.93 | |
13 | Current Drug Safety | journal | 0.348 Q3 | 41 | 32 | 134 | 959 | 144 | 123 | 1.10 | 29.97 | 49.31 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®